ReviewCancer drug resistance (Alhambra, Calif.)2022

Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer.

Yunchang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.